As detailed below, two potential return-on-investment results for each of these Covered Calls positions are:
- For Intel Corp.: +1.9% absolute return (equivalent to +87.5% annualized return-on-investment for the next 8 days) if the stock is assigned early (business day prior to the November 5th ex-dividend date); OR (2) +2.7% absolute return (equivalent to +41.2% annualized return over the next 24 days) if the stock is assigned on the November 20th options expiration date.
- For Pfizer Inc.: +1.6% absolute return (equivalent to +75.0% annualized return-on-investment for the next 8 days) if the stock is assigned early (business day prior to the November 5th ex-dividend date); OR (2) +2.8% absolute return (equivalent to +42.3% annualized return over the next 24 days) if the stock is assigned on the November 20th options expiration date.
1. Intel Corp. (INTC) -- New Covered Calls Position
The buy/write transaction was:
10/28/2020 Bought 200 Intel shares @ $44.64
10/28/2020 Sold 2 Intel 11/20/2020 $42.50 Call options @ $2.94
Note: the Time Value (aka Extrinsic Value) in the Call options was $.80 per share = [$2.94 Call options premium - ($44.64 stock price - $42.50 strike price)]
11/05/2020 Upcoming quarterly ex-dividend of $.33 per share
Two possible overall performance results (including commissions) for this Intel Covered Calls position are as follows:
Covered Calls Cost Basis: $8,341.34
= ($44.64 - $2.94) * 200 shares + $1.34 commission
Net Profit Components:
(a) Options Income: +$588.00
= ($2.94 * 200 shares)
(b) Dividend Income (If option exercised early on Nov 4th, the business day prior to the Nov 5th ex-div date): +$0.00; or
(b) Dividend Income (If Intel stock assigned at November 20th, 2020 expiration): +$66.00
= ($.33 dividend per share x 200 shares)
(c) Capital Appreciation (If Intel Call options assigned early on Nov 4th): -$428.00
+($42.50 - $44.64) * 200 shares; or
(c) Capital Appreciation (If INTC shares assigned at $120.00 strike price at options expiration): -$428.00
+($42.50 - $44.64) * 200 shares
+($42.50 - $44.64) * 200 shares; or
(c) Capital Appreciation (If INTC shares assigned at $120.00 strike price at options expiration): -$428.00
+($42.50 - $44.64) * 200 shares
1. Total Net Profit [If option exercised on Nov 4th (business day prior to Nov 5th ex-dividend date)]: +$160.00
= (+$588.00 options income +$0.00 dividend income -$428.00 capital appreciation); or
2. Total Net Profit (If Intel shares assigned at $42.50 strike price at November 20th, 2020 expiration): +$226.00
= (+$588.00 +$66.00 -$428.00)
1. Absolute Return (If two Intel Call options exercised early on Nov 4th): +1.9%
= +$160.00/$8,341.34
Annualized Return (If option exercised early): +87.5%
= (+$160.00/$8,341.34)*(365/8 days); or
2. Absolute Return (If Intel shares assigned at $42.50 at Nov 20th, 2020 options expiration): +2.7%
= +$226.00/$8,341.34
Annualized Return (If Intel shares assigned at $42.50 at Nov 20th, 2020 expiration): +41.2%
= (+$226.00/$8,341.34)*(365/24 days)
Either outcome provides an attractive return-on-investment result for this Intel investment. These returns will be achieved as long as the stock is above the $42.50 strike price at assignment. If the stock declines below the strike price, the breakeven price of $41.37 ($44.64 -$2.94 -$.33) provides 7.3% downside protection below today's stock purchase price.
At least eight of the nine metrics used in the Covered Calls Advisor's Dividend Capture Strategy spreadsheet must be 'YES' prior to establishing a position. As shown below with this Intel position, all nine criteria were met.
The buy/write transaction was:
10/28/2020 Bought 400 Pfizer shares @ $36.24
10/28/2020 Sold 4 Pfizer 11/20/2020 $34.00 Call options @ $2.79
Note: the Time Value (aka Extrinsic Value) in the Call options was $.55 per share = [$2.79 Call options premium - ($36.24 stock price - $34.00 strike price)]
11/05/2020 Upcoming quarterly ex-dividend of $.38 per share
Two possible overall performance results (including commissions) for this Pfizer Inc. Covered Calls position are as follows:
Covered Calls Cost Basis: $13,382.68
= ($36.24 - $2.79) * 400 shares + $2.68 commission
Net Profit Components:
(a) Options Income: +$1,116.00
= ($2.79 * 400 shares)
(b) Dividend Income (If option exercised early on Nov 4th, the business day prior to the Nov 5th ex-div date): +$0.00; or
(b) Dividend Income (If Pfizer stock assigned at Nov 20th, 2020 expiration): +$152.00
= ($.38 dividend per share x 400 shares)
(c) Capital Appreciation (If Pfizer Call options assigned early on Nov 4th): -$896.00
+($34.00 - $36.24) * 400 shares; or
(c) Capital Appreciation (If shares assigned at $34.00 strike price at options expiration): -$896.00
+($34.00 - $36.24) * 400 shares
+($34.00 - $36.24) * 400 shares; or
(c) Capital Appreciation (If shares assigned at $34.00 strike price at options expiration): -$896.00
+($34.00 - $36.24) * 400 shares
1. Total Net Profit [If option exercised on Nov 4th (business day prior to Nov 5th ex-dividend date)]: +$220.00
= (+$1,116.00 options income +$0.00 dividend income -$896.00 capital appreciation); or
2. Total Net Profit (If Pfizer shares assigned at $34.00 strike price at November 20th, 2020 expiration): +$372.00
= (+$1,116.00 +$152.00 -$896.00)
1. Absolute Return (If option exercised early on Nov 4th): +1.6%
= +$220.00/$13,382.68
Annualized Return (If option exercised early): +75.0%
= (+$220.00/$13,382.68)*(365/8 days); or
2. Absolute Return (If Pfizer shares assigned at $34.00 at Nov 20th, 2020 options expiration): +2.8%
= +$372.00/$13,382.68
Annualized Return (If Pfizer shares assigned at $34.00 at Nov 20, 2020 expiration): +42.3%
= (+$372.00/$13,382.68)*(365/24 days)
Either outcome provides an attractive return-on-investment result for this Pfizer investment. These returns will be achieved as long as the stock is above the $34.00 strike price at assignment. If the stock declines below the strike price, the breakeven price of $33.07 ($36.24 -$2.79 -$.38) provides 8.7% downside protection below today's stock purchase price.
At least eight of the nine metrics used in the Covered Calls Advisor's Dividend Capture Strategy spreadsheet must be 'YES' prior to establishing a position. As shown below with this Pfizer position, all nine criteria were met.